Leukocyte adhesion deficiency type I

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →
Download CSV

At a Glance

Live from database

Regulatory Watchboard

No FDA or trial events recorded yet for Leukocyte adhesion deficiency type I.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

0

Total programs

No financial assistance programs currently listed for Leukocyte adhesion deficiency type I.
Check the disease page for updates →

Clinical Trial Landscape

No active clinical trials currently recruiting for Leukocyte adhesion deficiency type I.
Search all trials →
Search clinical trials for Leukocyte adhesion deficiency type I

Recent News & Research

1 article
BREAKINGFDAMar 26, 2026

FDA Approves First Gene Therapy for Severe Leukocyte Adhesion Deficiency Type I

The U.S. Food and Drug Administration today approved Kresladi (marnetegragene autotemcel), the first gene therapy for the treatment of severe Leukocyte Adhesion Deficiency Type I (LAD-I).

Read ↗

Browse all Leukocyte adhesion deficiency type I news →

Specialist Network

Top 6 by expertise

View all Leukocyte adhesion deficiency type I specialists →

Quick Actions